<DOC>
	<DOCNO>NCT01635387</DOCNO>
	<brief_summary>Hypertensive haemodialysis patient high risk cardiovascular event . This study undertaken ascertain whether upstream aliskirne , direct renin inhibitor improve mortality cardiovascular outcome high-risk population .</brief_summary>
	<brief_title>RAAS Inhibitor Drugs Dialysis Patients</brief_title>
	<detailed_description />
	<mesh_term>Kidney Failure , Chronic</mesh_term>
	<criteria>chronic kidney disease stage 5 undergoing maintenance haemodialysis minimum 3 month exist arterial hypertension history arterial hypertension rest blood pressure â‰¥140/90 mmHg antihypertensive medication man female 18 year old . recent myocardial infarction ( le 3 month ) atrial fibrillation/atrial flutter hypotension systolic blood pressure &lt; 90 mmHg highgrade aortic stenosis leave ventricular ejection fration &lt; 50 % know allergy aliskiren severe disorder liver function</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2012</verification_date>
</DOC>